Sandra Lee
0000-0002-8198-0367
Publication & Citation Trends
Publications
0 total
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Influence on Soluble and Membrane Bound ICOS in Combination with Immune Checkpoint Blockade. OA
Cited by 3
Semantic Scholar
A Lasso Cox score consisting of CTLA4+ regulatory T cells (Treg), monocytic myeloid derived suppressor cells (M-MDSC), and CXCR3+ CD8+ T cells: Association with adjuvant ipilimumab (ipi) survival outcomes in patients (pts) with high-risk melanoma.
Cited by 1
Semantic Scholar
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review OA
Cited by 10
Semantic Scholar
Abstract 5704: An integrated immune signature predictive of adjuvant immunotherapeutic benefits for high-risk melanoma
Cited by 0
Semantic Scholar
Impact of immune checkpoint inhibition on ovarian reserve in patients with melanoma enrolled in the ECOG-ACRIN E1609 adjuvant trial.
Cited by 12
Semantic Scholar
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134 OA
Cited by 329
Semantic Scholar
Early quality of life (QOL) and symptom analysis from the DREAMseq phase III randomized control trial of combination immunotherapy versus targeted therapy in patients (pts) with BRAF-mutant metastatic melanoma (MM) (ECOG-ACRIN EA6134).
Cited by 1
Semantic Scholar
Research Topics
Mitochondrial Function and Pathology
(8)
ATP Synthase and ATPases Research
(4)
Neuroscience and Neuropharmacology Research
(2)
Ion channel regulation and function
(2)
Liver Disease Diagnosis and Treatment
(1)
Affiliations
University of Utah